Moderna (NASDAQ: MRNA)
Moderna Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Moderna Company Info
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA).
News & Analysis
2 Artificial Intelligence (AI) in Healthcare Stocks to Buy and Hold for Great Long-Term Potential
These companies have gotten in on AI early and could emerge as winners.
1 New Green Flag for Moderna and Merck Stock
There's a new reason to believe that their joint projects are going well.
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
These companies are close to launching new products that could supercharge revenue.
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
These stocks, a bargain today, are players to hold on to for the long term.
Is Moderna Stock Going to $214? 1 Wall Street Analyst Thinks So.
Moderna, famous for its coronavirus vaccine, is only at the start of a trip skyward, a market professional believes.
Moderna Stock: Buy, Sell, or Hold?
Moderna is more than its COVID-19 vaccine, but risks for investors still exist.
Better Cathie Wood Stock: Moderna vs. Intellia
Moderna and Intellia have declined in the double digits over the past year.
A Bull Market Is Here: 2 Magnificent Stocks Down 30% or More to Buy Right Now
These stocks share several things in common.
Valuation
Podcast Episodes
Microsoft's Gaming Ambitions and COVID-19 Stocks
Microsoft CEO Satya Nadella talked about his company's doubling down on gaming, which should give gamers and investors pause.
What Gives Moderna's Coronavirus Vaccine an Edge?
Moderna has got some promising news on the coronavirus vaccine front.
Why Moderna Stock Is Up
Moderna shares got a boost as the company continued its COVID-19 vaccine trials.
Why Moderna Stock Just Went Up
Encouraging news coming out of the biotech regarding its coronavirus vaccine candidate caused its stock to pop.
Earnings Transcripts
Moderna (MRNA) Q4 2023 Earnings Call Transcript
MRNA earnings call for the period ending December 31, 2023.
Moderna (MRNA) Q3 2023 Earnings Call Transcript
MRNA earnings call for the period ending September 30, 2023.
Moderna (MRNA) Q2 2023 Earnings Call Transcript
MRNA earnings call for the period ending June 30, 2023.
Moderna (MRNA) Q1 2023 Earnings Call Transcript
MRNA earnings call for the period ending March 31, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.